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Abstract
Background: Infective endocarditis is significantly more common in haemodialysis patients as
compared with the general population, the causative pathogen is generally Staphylococcus aureus;
there have been no previously reported cases of infective endocarditis caused by a Salmonella
species in haemodialysis patients.
Case Presentation: We report the case of a 68 year-old woman on haemodialysis who
developed infective endocarditis as a result of Salmonella enteritidis. Although we treated the
patient with ceftriaxone combined with ciprofloxacin, infective endocarditis was not detected early
enough and unfortunately developed into cerebral septic emboli, which ultimately resulted in death.
Conclusion: Although there are several reports that Salmonella endocarditis without cardiac
failure can be successfully treated with antibiotics alone, early surgical intervention is essential for
some cases to prevent life-threatening complications. Transesophageal echocardiography should be
performed in any patient with high clinical suspicion of infective endocarditis. To the best of our
knowledge, this is the first case-report of Salmonella endocarditis in a haemodialysis patient.
Background
Infective endocarditis is significantly more common in
haemodialysis patients as compared with the general pop-
ulation. In addition to the four conventional categories of
infective endocarditis (native valve infective endocarditis,
prosthetic valve infective endocarditis, infective endocar-
ditis in intravenous drug users, and nosocomial infective
endocarditis), a fifth category, health-care associated
infective endocarditis or haemodialysis associated infec-
tive endocarditis, has recently been proposed. Although
infective endocarditis is a common complication among
haemodialysis patients, the causative pathogen is gener-
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ally Staphylococcus aureus; there have been no reported
cases of infective endocarditis caused by a Salmonella spe-
cies in haemodialysis patients. Salmonella  species have
been reported to cause bacteremia [1] and infective endo-
carditis in 5 and 1.4% of patients [2] during gastrointesti-
nal infections, respectively. However, in general, cases of
infective endocarditis due to Salmonella species are rela-
tively rare. Here, we report the case of a 68 year-old
woman on haemodialysis who developed infective endo-
carditis on her native mitral valve as a result of Salmonella
enteritidis. After hospitalization, the patient was treated
with intensive antibiotic therapy. However, the infective
endocarditis was not detected early enough and unfortu-
nately developed into cerebral septic emboli, which ulti-
mately resulted in death.
Case Presentation
A 68 year-old Asian woman was admitted to our hospital
presenting with a two-day history of high grade fever,
diarrhea and nausea. The patient's symptoms began one
day after eating grilled chicken and beef at a restaurant;
however, she did not complain of abdominal pain, vom-
iting, or hematochezia. The patient was diagnosed with
diabetes mellitus at the age of 50, had undergone haemo-
dialysis due to diabetic nephropathy for the past 2 years,
and was under three times weekly haemodialysis. She had
also undergone an aortic mechanical valve replacement
operation for aortic stenosis 7 months prior to the current
admission.
Upon admission to our hospital, the patient's height was
149 cm and her body weight were 61.0 kg (dry weight).
The patient's temperature was 106°F, blood pressure was
150/90 mmHg, heart rate was 152/min, and respiratory
rate was 24/min. Cardiovascular examination revealed a
Levine IV/VI systolic murmur at the right second intercos-
tal space. Her bowel movements were slightly hypoactive
and physical examination did not reveal any abdominal
tenderness or rebound. No evidence of embolization
including Osler node, Janeway lesion and petechiae was
observed. No other abnormalities were noted on the sys-
temic examination. Initial laboratory examinations
revealed the following results: hemoglobin, 115 g/L [110-
146 g/L]; total leukocyte counts, 10300/μL [3500-8200/
μL] without left shift (Myelo 0.5%, Meta 0.5%, Stab 2.0%,
Seg 90.0%, Lym 1.5%, Mono 5.5%); normal platelet
counts, 1.42 × 103/μL [1.40-3.89 × 103/μL]; significantly
elevated C-reactive protein, 18.54 mg/dL [<0.30 mg/dL];
Na 131 mEq/L, K 4.3 mEq/L, Cl 97 mEq/L, HCO3- 18.9
mmol/L; BUN 43.6 mg/dL, Cre 7.25 mg/dL (before
haemodialysis); serum glucose, 173 mg/dL; and HbA1c,
7.3% [4.3-5.8%]. In addition, the patient was tested neg-
ative for HIV antibodies.
Salmonella enteritis or campylobacter enteritis was sus-
pected due to the history of eating grilled chicken. Treat-
ment was initiated with ciprofloxacin 300 mg q24hr,
ceftriaxone 2 g q24hr, and clindamycin 600 mg q12hr
intravenously, started on day of admission. Three days
post-admission, a serial blood culture taken on admission
revealed Salmonella enterica serotype Enteritidis (O9, H-
g) that was sensitive to ceftriaxone (MIC <= 1) and cipro-
floxacin (MIC <= 0.25) (Table 1). After detection of the
causable microorganism, ceftriaxone and clindamycin
treatment was ceased, and the patient was treated with
ciprofloxacin alone. Since the patient's aortic valve was a
prosthetic, and Salmonella species have a high affinity for
intravascular intima, there was a concern about prosthetic
infective endocarditis. Therefore, the patient underwent
transthoracic echocardiography (TTE) on day 7; however,
no abnormalities were detected by TTE. On day 9, the
patient showed a sudden disturbance in mental status, left
conjugate deviation, and right hemiplegia. Diffusion-
weighted imaging of the brain via MRI showed an acute
cerebral infarction of the middle cerebral artery region
(figure 1). Following this discovery, the TTE was re-exam-
ined, followed by a transesophageal echocardiography
(TEE) on day 13. The TEE revealed floppy vegetation on
the mitral valve, which was 12 × 8 mm in size (figure 2).
We could not find any aberrance of the replaced aortic
valve. Although surgery to remove the vegetation was con-
sidered, acute cerebral infarction contraindicated her from
undergoing the operation. The ciprofloxacin dose was
increased to 400 mg q24hr and was combined with ceftri-
axone 2q q12hr, on day 12. Consequently, the patient was
Table 1: Susceptibility of the Salmonella Enteritidis to the 
Antibiotics
Antibiotics MIC Sensitivity
CEZ <=4 R
AMK <=2 R
TOB <=1 R
GM <=1 R
AZT <=1 S
CTRX <=1 S
CAZ <=1 S
ABPC <=2 S
PIPC <=4 S
CPFX <=0.25 S
ST <=20 S
S/A <=2 S
MEPM <=0.25 S
CFPM <=1 S
PIPC/TAZ <=4 S
Abbreviations: CEZ; cefazolin, AMK; amikacin, TOB; tobramycin, GM; 
gentamicin, AZT; aztronam, CTRX; ceftriaxone, CAZ; ceftazidime, 
ABPC; ampicillin, PIPC; piperacillin, CPFX; ciprofloxacin, ST; 
sulfamethoxazole-trimethoprim, S/A; ampicillin sulbactam, MEPM; 
meropenem, CFPM; cefepime, PIPC/TAZ; piperacillin-tazobactamBMC Infectious Diseases 2009, 9:161 http://www.biomedcentral.com/1471-2334/9/161
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treated solely with ciprofloxacin for 8-day period (from
day 4 to day 11). Although the patient's neurological def-
icit ameliorated gradually, she experienced another infarc-
tion at the left occipital lobe and the right cerebellar
hemisphere on day 18. Conservative therapy with antibi-
otics was continued; however, her mental status progres-
sively decreased and blood pressure deteriorated. Blood
culture examinations were repeated, but they were all neg-
ative. haemodialysis ceased on day 35 due to the unstable
haemodynamic status, although treatment with cipro-
floxacin and ceftriaxone were continued. On day 39, the
patient died of respiratory failure and cardiac arrest. Her
clinical course is shown in figure 3. Autopsy revealed a
rigid node on the mitral valve (figure 4), associated with
septic emboli (mass of gram-negative microorganisms) at
the left occipital lobe (figure 5).
Discussion
Infective endocarditis is a common complication of
haemodialysis, the incidence of which is 1.7-2.0 cases/
1000 patients in France (50-60 times higher than the gen-
eral population), and 483 cases per 100,000 person-years
in the United States of America (74 times higher than the
general population) [3,4]. The most common causable
pathogen is Staphylococcus aureus, which contributes to 40-
80% of the cases (Table 2). A report from Duke University
Medical Center during 1993-1999 demonstrated that the
overall proportion of haemodialysis patients out of a total
of 329 infective endocarditis patients increased from
6.7% to 20% over the 7 year study period. In addition,
there was a significant increase in Staphylococcus aureus as
the causable agent [5]. We experienced 46 infective endo-
carditis patients in our hospital during 2003-2008, 4 of
which were haemodialysis patients (8.7%) [6]. The mitral
valve (up to 50% of cases) and the aortic valve (up to 40%
of cases) are the most commonly affected valves for infec-
tive endocarditis in haemodialysis patients [7-9]. To the
best of our knowledge, this is the first English report of
Salmonella infective endocarditis in a haemodialysis
patient.
Gastroenteritis due to Salmonella species occurs relatively
frequently; however, it is a rare cause of infective endocar-
Diffusion-weighted image of the brain MRI taken on day 9  with high intensity areas on the left middle cerebral artery  region Figure 1
Diffusion-weighted image of the brain MRI taken on 
day 9 with high intensity areas on the left middle cer-
ebral artery region.
Transthoracic echocardiogram (A) and transesophageal  echocardiogram (B) performed on day 13 revealed vegeta- tion on the mitral valve Figure 2
Transthoracic echocardiogram (A) and transesopha-
geal echocardiogram (B) performed on day 13 
revealed vegetation on the mitral valve.BMC Infectious Diseases 2009, 9:161 http://www.biomedcentral.com/1471-2334/9/161
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ditis. Guerrero identified a total of 72 cases of Salmonella
endocarditis within the English literature in 2004; 42
cases before 1987 and 30 cases in 1987-2004 [10]. In a
population-based study, Nielsen reported 111 cases of
Salmonella bacteremia from 1994 through 2003 in North
Jutland Country, Denmark. Among them, there were only
2 cases (1.8%) of endocarditis documented [11]. Tran-
sient bacteremia is reported to be present in 5-10% of
patients with Salmonella gastroenteritis. Within these
cases, the incidence of infective endocarditis is approxi-
mately 2.0% [11].
The intravascular intima is vulnerable to Salmonella spe-
cies, thus reflecting the ability of salmonella to cause
endothelial infections in the presence of atherosclerosis.
The risk of endovascular focal infection in elderly patients
(age>50) with Salmonella bacteremia is reported to be 7-
Laboratory data, body temperature, and antibiotics administered to the patient after admission to the hospital Figure 3
Laboratory data, body temperature, and antibiotics administered to the patient after admission to the hospi-
tal. Abbreviations: WBC; white blood cell, BT; body temperature, CRP; C-reactive protein, TTE; transthoracic echocardiogra-
phy, TEE; transesophageal echocardiography, CPFX; ciprofloxacin, CTRX; ceftriaxone, CLDM; clindamycin
A rigid node on the mitral valve (arrow), found during  autopsy (A, B) Figure 4
A rigid node on the mitral valve (arrow), found dur-
ing autopsy (A, B).BMC Infectious Diseases 2009, 9:161 http://www.biomedcentral.com/1471-2334/9/161
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23% [10-12]. The prognosis of Salmonella endocarditis is
improving; Cohen reported the mortality of 69% (29/42)
in 1987 [13], where as Guerrero identified the mortality of
20% (6/30) in 1987-2004 [10]. Guerrero concluded that
surgery has played an essential role in reducing the mor-
tality of Salmonella endocarditis, and surgical interven-
tion, including valve replacement, increases survival in
Salmonella endocarditis and is the treatment of choice for
patients with cardiac failure, persisting sepsis and for
those who relapse after discontinuation of antimicrobial
therapy. Early surgical intervention may prevent life-
threatening complications including cerebral infarction
[14,15], as was observed in the current case. In this case,
Salmonella species were suspected from the medical his-
tory. Therefore, we began the appropriate treatment of
ceftriaxone combined with ciprofloxacin, and performed
an early investigation with TTE; however, we failed to
detect infective endocarditis before it induced cerebral inf-
arction. The cerebral infarction contraindicated her from
early surgical intervention. Owing to the increased sensi-
tivity of TEE over TTE in detecting vegetations (Sensitivity
for native valve: TTE 60-65%, TEE 85-95%) [16], TEE
should be performed in any haemodialysis patient with
high clinical suspicion of infective endocarditis, and
whenever bacteremia with organisms typical for infective
endocarditis was detected. It should also be emphasized
that in patients with prosthetic valve, TEE is mandatory
for those suspected to have infective endocarditis, owing
to unacceptably low sensitivity of TTE for detecting infec-
tive endocarditis of the prosthetic valve (Sensitivity for
prosthetic valve: TTE <50%, TEE 82-90%) [16]. Identifica-
tion of the optimal treatment for Salmonella endocarditis
requires further investigation. In addition, the emergence
of ceftriaxone-resistant Salmonella  species has recently
been reported [17,18]. Due to this resistance, combina-
tion treatment with a third generation cephalosporin and
a fluoroquinolone is offered in life-threatening infections.
We treated the patient in this case study with cipro-
floxacin, and later combined with ceftriaxone; however,
we failed to prevent the patient from developing cerebral
infarction, which was identified as septic emboli upon
autopsy.
Conclusion
Salmonella endocarditis has been previously reported in
the general population as a rare complication of Salmo-
nella gastroenteritis. To the best of our knowledge, this is
the first case-report of Salmonella endocarditis in a
haemodialysis patient. Salmonella endocarditis may
present an aggressive course; therefore, early surgical inter-
vention is essential for some cases to prevent life-threaten-
ing complications. Non-surgical management may treat
the patient successfully, but further investigation is
required to distinguish patients who require an expedi-
tious surgical intervention from those who can be treated
with antibiotics alone.
Table 2: Previously published reports of causable organisms for infective endocarditis in haemodialysis patients
Nori et al.
[17]
Spies et al.
[9]
Doulton et al.
[18]
Maraj et al.
[8]
McCarthy & Steckelberg
[7]
Episodes of infective endocarditis N = 54 N = 40 N = 30 N = 30 N = 17
Staphylococcus aureus 40% 50% 63% 80% 40%
MRSA 20% 15% 7% 23%
CNS 22% 12% 13% 3% 10%
Enterococcus sp. 33% 23% 10% 7% 20%
Streptococcus sp. 10% 3% 25%
Gram-negative sp. 13% 10%
Candida sp. 3% 3%
Aspergillus sp. 5%
Negative blood culture 2% 10%
Bacterial proliferation in the cerebral infarction Figure 5
Bacterial proliferation in the cerebral infarction.Publish with BioMed Central    and   every 
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